An elevated prostate-specific antigen (PSA) level and abnormal digital rectal examination (DRE) finding will prompt the clinician to perform a prostate needle biopsy for the diagnosis of prostate cancer. The gene discussed is KLK3; the disease is prostate carcinoma.